DE60218375D1 - Pharmazeutische Zusammensetzung zur Behandlung gynäkologischer Erkrankungen - Google Patents

Pharmazeutische Zusammensetzung zur Behandlung gynäkologischer Erkrankungen

Info

Publication number
DE60218375D1
DE60218375D1 DE60218375T DE60218375T DE60218375D1 DE 60218375 D1 DE60218375 D1 DE 60218375D1 DE 60218375 T DE60218375 T DE 60218375T DE 60218375 T DE60218375 T DE 60218375T DE 60218375 D1 DE60218375 D1 DE 60218375D1
Authority
DE
Germany
Prior art keywords
treatment
pharmaceutical composition
gynecological diseases
gynecological
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60218375T
Other languages
English (en)
Inventor
Nobuhiko Yui
Kouichi Murakami
Tooru Ooya
Ikuo Sato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JNC Corp
Original Assignee
Chisso Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chisso Corp filed Critical Chisso Corp
Application granted granted Critical
Publication of DE60218375D1 publication Critical patent/DE60218375D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0039—Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE60218375T 2001-03-30 2002-03-27 Pharmazeutische Zusammensetzung zur Behandlung gynäkologischer Erkrankungen Expired - Fee Related DE60218375D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001100426 2001-03-30

Publications (1)

Publication Number Publication Date
DE60218375D1 true DE60218375D1 (de) 2007-04-12

Family

ID=18953869

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60218375T Expired - Fee Related DE60218375D1 (de) 2001-03-30 2002-03-27 Pharmazeutische Zusammensetzung zur Behandlung gynäkologischer Erkrankungen

Country Status (3)

Country Link
US (1) US7041310B2 (de)
EP (1) EP1249247B1 (de)
DE (1) DE60218375D1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7799766B2 (en) * 1998-04-08 2010-09-21 Theta Biomedical Consulting & Development Co., Inc. Composition for treating hormonally-dependent cancers
DE10147186A1 (de) * 2001-09-25 2003-04-24 Beiersdorf Ag Wirkstoffkombinationen aus Polyhexamethylenbiguanid-Hydrochlorid und Distearyldimethylammoniumchlorid und Zubereitungen, solche Wirkstoffkombinationen enthaltend
MXPA05007266A (es) * 2003-01-02 2006-01-17 Femmepharma Holding Co Inc Preparaciones farmaceuticas para tratamientos de enfermedades y trastornos del seno.
US9173836B2 (en) 2003-01-02 2015-11-03 FemmeParma Holding Company, Inc. Pharmaceutical preparations for treatments of diseases and disorders of the breast
JP4459543B2 (ja) * 2003-03-17 2010-04-28 株式会社メドジェル 徐放性ハイドロゲル製剤
JP2004323454A (ja) * 2003-04-25 2004-11-18 Chisso Corp 薬剤
US7276486B2 (en) * 2004-03-15 2007-10-02 Kimberly-Clark Worldwide, Inc. Compositions for vaginal treatment
US20050220912A1 (en) * 2004-03-30 2005-10-06 Theoharides Theoharis C Anti-inflammatory composition for treating pelvic endometriosis
US20070154546A1 (en) * 2005-12-30 2007-07-05 Zhang Jack Y Sustained release pharmaceutical compositions
WO2008083158A2 (en) * 2006-12-26 2008-07-10 Femmepharma Holding Company, Inc. Topical administration of danazol
US20080287408A1 (en) * 2007-05-14 2008-11-20 Drugtech Corporation Endometriosis treatment
US8282612B1 (en) 2008-03-07 2012-10-09 Denise H. Miller Methods and devices for intrauterine absorption
US20110003000A1 (en) * 2009-07-06 2011-01-06 Femmepharma Holding Company, Inc. Transvaginal Delivery of Drugs
US9078786B1 (en) 2012-10-19 2015-07-14 Denise H. Miller Methods and devices for collecting body fluids
CZ2013914A3 (cs) 2013-11-21 2015-02-25 Contipro Biotech S.R.O. Nanovlákna obsahující fototvrditelný esterový derivát kyseliny hyaluronové nebo její soli, fototvrzená nanovlákna, způsob jejich syntézy, přípravek obsahující fototvrzená nanovlákna a jejich použití
CN108853569B (zh) * 2018-06-27 2021-06-11 湖南玉津医疗科技有限公司 一种共价交联透明质酸气凝胶及其水凝胶以及制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4851521A (en) * 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
JP2590358B2 (ja) 1988-03-01 1997-03-12 正雄 五十嵐 子宮内膜症治療用の子宮内又は膣内投与製剤
IT1247472B (it) * 1991-05-31 1994-12-17 Fidia Spa Processo per la preparazione di microsfere contenenti componenti biologicamente attivi.
JP2855307B2 (ja) 1992-02-05 1999-02-10 生化学工業株式会社 光反応性グリコサミノグリカン、架橋グリコサミノグリカン及びそれらの製造方法
IT1260154B (it) 1992-07-03 1996-03-28 Lanfranco Callegaro Acido ialuronico e suoi derivati in polimeri interpenetranti (ipn)
JP3390477B2 (ja) * 1993-01-25 2003-03-24 生化学工業株式会社 薬剤組成物及びその製造法
JP3563440B2 (ja) 1994-05-16 2004-09-08 生化学工業株式会社 アシル化ヒアルロン酸の製造法
EP0725083B1 (de) 1994-08-11 2001-11-28 Shiseido Company Limited Acetylierte hyaluronsäure mit niedrigem molekulargewicht; aufweichmittel und verfahren zur herstellung und reinigung dieser säure
JP3556975B2 (ja) 1994-08-11 2004-08-25 株式会社資生堂 アセチル化ヒアルロン酸の製造方法及び精製方法
HU224697B1 (en) 1995-11-15 2006-01-30 Seikagaku Kogyo Co Ltd Photocured cross-linked-hyaluronic acid gel and method of preparation thereof
IT1317358B1 (it) * 2000-08-31 2003-06-16 Fidia Advanced Biopolymers Srl Derivati cross-linkati dell'acido ialuronico.
US6673919B2 (en) * 2001-03-30 2004-01-06 Chisso Cororation Chemically modified hyaluronic acid or salts thereof, and a process for producing thereof

Also Published As

Publication number Publication date
EP1249247A3 (de) 2003-01-15
US20020150605A1 (en) 2002-10-17
EP1249247B1 (de) 2007-02-28
EP1249247A2 (de) 2002-10-16
US7041310B2 (en) 2006-05-09

Similar Documents

Publication Publication Date Title
DE60232251D1 (de) Pharmazeutische zusammensetzungen zur behandlung von asthma
DE50206657D1 (de) Pharmazeutische zusammensetzung zur behandlung von multiple sklerose
ATE417606T1 (de) Phenethanolamin-derivate zur behandlung von erkrankungen der atemwege
DE60124302D1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
DE60320007D1 (de) Phenethanolamin-derivate zur behandlung von atemwegserkrankungen
DE602004029580D1 (de) Substituierte indolderivate für eine pharmazeutische zusammensetzung zur behandlung von atemwegserkrankungen
FIU20060389U0 (fi) Luusairauksien hoito
ATE512163T1 (de) Verabreichung von mitteln zur behandlung von entzündungen
NO20053077D0 (no) Terapeutiske formuleringer for behandling av beta-amyloid-relaterte sykdommer.
NO20033594L (no) Fenetanolamin-derivater for behandling av luftveissykdommer
DE602004028763D1 (de) Te zur behandlung von virenerkrankungen
IS7691A (is) Lyfjasamsetningar til að meðhöndla æxli
DE60142473D1 (de) Intrakorporale medikamente zur photodynamischen behandlung von erkrankungen
ATE551100T1 (de) Pharmazeutische zusammensetzung zur behandlung von kardiovaskulären und cerebrovasakulären erkrankungen
ATE440866T1 (de) Nogo-a-neutralisierende immunglobuline zur behandlung neurologischer krankheiten
ATE516037T1 (de) Topische formulierung von ivermectin zur behandlung von dermatologischen erkrankungen
DE60019814D1 (de) Pharmazeutische kombinationen enthaltend tegaserod und omeprazole und ihre verwendung zur behandlung gastrointestinaler krankheiten
ATE384522T1 (de) Medikamente zur chemotherapeutischen behandlung von erkrankungen
DE60218375D1 (de) Pharmazeutische Zusammensetzung zur Behandlung gynäkologischer Erkrankungen
DE60123238D1 (de) Zusammensetzungen zur behandlung von autoimmunkrankheiten
ATE313540T1 (de) Heterozyklische verbindungen zur behandlung von harnwegserkrankungen
ATE451123T1 (de) Vaginal verabreichbare zusammensetzung zur behandlung von uteriner dysrhythmie
DE60027209D1 (de) Arzneimittel enthaltend hydroxyapatite zur behandlung von knochengewebserkrankungen
ATE443704T1 (de) Pyridopyrimidinone zur behandlung von krebserkrankungen
DE60204466D1 (de) Integrinhemmer zur behandlung von augenkrankheiten

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee